VKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Viking Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$25.05−0.12 (-0.48%)
Close on Oct 19, 2026
- Market cap
- $2.91B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Viking Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 23, 2026 | Sep 28, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 22, 2026 | Sep 22, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Jul 29, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 29, 2026 | Jul 29, 2026 | SEC EDGAR |
| Current report | 8-K | May 19, 2026 | May 26, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 29, 2026 | Apr 29, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | May 19, 2026 | Apr 1, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 11, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 11, 2026 | Feb 11, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Oct 23, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 22, 2025 | Oct 22, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 19, 2025 | Aug 19, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Jul 23, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 23, 2025 | Jul 23, 2025 | SEC EDGAR |
| Current report | 8-K | May 20, 2025 | May 27, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | Apr 24, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 23, 2025 | Apr 23, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 18, 2025 | Apr 23, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | May 20, 2025 | Apr 8, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 10, 2025 | Mar 11, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 26, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 5, 2025 | Feb 5, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 4, 2024 | Nov 4, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Oct 23, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 23, 2024 | Oct 23, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Jul 24, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 24, 2024 | Jul 24, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2024 | Jun 4, 2024 | SEC EDGAR |
| Current report | 8-K | May 21, 2024 | May 23, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | Apr 25, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 24, 2024 | Apr 24, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | May 21, 2024 | Apr 5, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 26, 2024 | Mar 26, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 4, 2024 | Mar 4, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 28, 2024 | Mar 1, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 27, 2024 | Feb 27, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Feb 7, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 7, 2024 | Feb 7, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2023 | Oct 25, 2023 | SEC EDGAR |